Sema TURAN, Sultan SEVİM YAKIN, Levent YAMANEL

The timing of intubation and principles of ICU care in COVID-19

Abstract: Coronavirus disease-19 (COVID-19) has been a serious health problem since it was first identified in Wuhan, China, in December 2019 and has created a global crisis with its economic, sociological, and psychological aspects. Approximately 15% of cases have a severe clinical presentation, and 5% of patients require admission to the intensive care unit. A significant proportion of patients presents with a rapidly progressing acute respiratory failure and require invasive mechanical ventilation. This article aimed to evaluate how the optimal intubation timing should be determined in cases of acute respiratory failure due to COVID-19 and to offer recommendations for basic intensive care support in the light of our current knowledge.Key words: Coronavirus disease-19, intensive care unit, intubation

PDF

___

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. The Journal of the American Medical Association 2020; 323 (13): 1239-1242. doi: 10.1001/jama.2020.2648
2. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. The Journal of the American Medical Association 2020; 323 (16): 1574-1581. doi: 10.1001/jama.2020.5394
3. Zuo M, Huang Y, Ma W, Xue Z, Zhang J et al. Expert recommendations for tracheal intubation in critically ill patients with novel coronavirus disease 2019. Chinese Medical Sciences Journal 2020; 35 (2): 105-109. doi: 10.24920/003724
4. Brown CA, Mosier JM, Carlson JN, Gibbs MA. Pragmatic recommendations for intubating critically ill patients with suspected COVID-19. Journal of the American College of Emergency Physicians Open 2020; 1 (2): 80-84. doi: 10.1002/ emp2.12063
5. Tobin MJ, Laghi F, Jubran A. Caution about early intubation and mechanical ventilation in COVID-19. Annals of Intensive Care 2020; 10 (1): 78. doi: 10.1186/s13613-020-00692-6
6. Phua J, Weng L, Ling L, Egi M, Lim CM et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respiratory Medicine. 2020; 8 (5): 506-517. doi: 10.1016/S2213- 2600(20)30161-2
7. Li L, Gong S, Yan J. Covid-19 in China: ten critical issues for intensive care medicine. Critical Care 2020; 24 (1):124. doi: 10.1186/s13054-020-02848-z
8. Yang X, Yuan Y, Xu J, Shu H, Xia H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Medicine 2020; 8 (5): 475-481. doi: 10.1016/S2213-2600(20)30079-5
9. Zhou P, Yang XL, Wang XG, Ben H, Zhang L et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 588 (7836): E6. doi: 10.1038/s41586-020- 2951-z
10. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 2020; 382 (18):1708-1720. doi: 10.1056/NEJMoa2002032
11. Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine 2017; 195 (4): 438 – 442. doi: 10.1164/rccm.201605-1081CP
12. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID19 in the New York City Area. The Journal of the American Medical Association 2020; 323 (20): 2052-2059. doi: 10.1001/ jama.2020.6775
13. Combes A, Berneau JB, Luyt CE, Trouillet JL. Estimation of left ventricular systolic function by single transpulmonary thermodilution. Intensive Care Medicine 2004; 30 (7): 1377- 1383. doi: 10.1007/s00134-004-2289-2
14. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Medicine 2020; 46 (6): 1099-1102. doi: 10.1007/s00134-020-06033-2
15. Bos LDJ, Sinha P, Dickson RP. The perils of premature phenotyping in COVID-19: a call for caution. The European Respiratory Journal 2020; 56 (1): 2001768. doi: 10.1183/13993003.01768-2020
16. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus– infected pneumonia in Wuhan, China. The Journal of the American Medical Association 2020; 323 (11): 1061-1069. doi: 10.1001/jama.2020.1585
17. Meng L, Qiu H, Wan L, Ai Y, Xue Z et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology. 2020; 132 (6):1317-1332. doi: 10.1097/ ALN.0000000000003296
18. da Silva CM, do Nascimento Andrade A, Nepomuceno B, Xavier DS, Lima E et al. Evidence- based physiotherapy and functionality in adult and pediatric patients with COVID-19. Journal of Human Growth and Development 2020; 30 (1): 148- 155. doi: 10.7322/jhgd.v30.10086
19. Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine 2019; 45 (5): 563-572. doi: 10.1007/s00134-019-05590-5
20. Frat PJ, Thille AW, Mercat A, Girault C, Ragot S et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. The New England Journal of Medicine 2015; 372 (23): 2185-2196. doi: 10.1056/NEJMoa1503326
21. Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. The Journal of the American Medical Association 2016; 315 (22): 2435-2441. doi: 10.1001/jama.2016.6338
22. Pisani L, Astuto M, Prediletto I, Longhini F. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019; 25 (6): 348-354. doi: 10.1016/j. pulmoe.2019.08.001
23. Grieco DL, Menga LS, Raggi V, Bongiovanni F, Anzellotti GM et al. Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure. American Journal of Respiratory and Critical Care Medicine 2020; 201 (3): 303-312. doi: 10.1164/rccm.201904- 0841OC
24. Mughal MS, Kaur IP, Jaffery AR, Dalmacion DL, Wang C et al. COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity. Respiratory Medicine 2020; 172: 106130. doi: 10.1016/j. rmed.2020.106130
25. Barlass U, Wiliams B, Dhana K, Adnan D, Khan SR et al. Marked elevation of lipase in covid-19 disease: a cohort study. Clinical and Translational Gastroenterology 2020; 11 (7): e00215. doi: 10.14309/ctg.0000000000000215
26. Yang X, Yu Y, Xu J, Shu H, Xia J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine 2020; 8 (5): 475-481. doi: 10.1016/S2213-2600(20)30079-5
27. Agarwal A, Basmaji J, Muttalib F, Granton D, Chaudhuri D et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection. Canadian Journal of Anesthesia 2020; 67 (9):1217- 1248. doi: 10.1007/s12630-020-01740-2
28. Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. The Journal of the American Medical Association 2020; 323 (22): 2329-2330. doi: 10.1001/jama.2020.6825
29. Arnal JM, Chatburn R. Paying attention to patient self-inflicted lung injury. Minerva Anestesiologica 2019; 85 (9): 940-942. doi: 10.23736/S0375-9393.19.13778-9
30. Bavishi AA. Mylvaganam RJ, Agarwal R, Avery RJ, Cuttica MJ et al. Timing of intubation in coronavirus disease 2019: A study of ventilator mechanics, imaging, findings, and outcomes. Critical Care Explorations 2021; 3 (5): e0415. doi: 10.1097/ CCE.0000000000000415
31. Siempos II, Xourgia E, Ntaidou TK, Zervakis D, Magira EE et al. Effect of early vs. delayed or no intubation on clinical outcomes of patients with COVID-19: an observational study. Frontiers in Medicine (Lausanne) 2020; 7: 614152. doi: 10.3389/fmed.2020.614152
32. Patel M, Chowdhury J, Mills N, Marron R, Gangemi A et al. ROX index predicts intubation in patients with COVID-19 pneumonia and moderate to severe hypoxemic respiratory failure receiving high flow nasal therapy. medRxiv 2020. doi: 10.1101/2020.06.30.20143867.
33. Hur K, Price CP, Gray EL, Gulati RK, Maksimoski M et al. Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19. Otolaryngology Head and Neck Surgery 2020; 163 (1): 170-178. doi: 10.1177/0194599820929640
34. Zheng H, Li S, Sun R, Yang H, Chi X et al. Clinical experience with emergency endotracheal intubation in COVID-19 patients in the intensive care units: a single-centered, retrospective, descriptive study. American Journal of Translational Research 2020; 12 (10): 6655-6664
35. Orser BA. Recommendations for endotracheal intubation of COVID-19 patients. Anesthesia and Analgesia 2020; 130 (5): 1109-1110. doi: 10.1213/ANE.0000000000004803
36. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A et al. Consensus guidelines for managing the airway in patients with COVID19: Guidelines from the difficult airway society, the association of anesthetists the intensive care society, the faculty of intensive care medicine and the royal college of anaesthetists. Anaesthesia 2020; 75 (6): 785-799. doi: 10.1111/ anae.15054
37. Brewster DJ, Chrimes N, Do TBT, Fraser K, Groombridge CJ et al. Consensus statement: safe airway society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. The Medical Journal of Australia 2020; 212 (10): 472-481. doi: 10.5694/mja2.50598
38. Lee HY, Choi KJ, Choi SH, Lee SY, Kim KC et al. Clinical significance of timing intubation in critically ill patients with COVID-19: A multicenter retrospective study. Journal of Clinical Medicine 2020; 9 (9): 2847. doi: 10.3390/jcm9092847
39. Zhou F, Yu T, Du R, Fan G, Liu Y et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
40. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R et al. Clinical characteristics of COVID- 19 in New York city. The New England Journal of Medicine 2020; 382 (24): 2372-2374. doi: 10.1056/NEJMc2010419
41. Mohammadi M, Varpaei HA, Amini M. Intubation prognosis in COVID-19 patients and associated factors: a crosssectional study. Research Square. 2020; Epub. doi: 10.21203/ rs.3.rs-115894/v1
42. Huang C. Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506. doi: 10.1016/S0140- 6736(20)30183-5
43. Cardona S, Downing J, Alfalasi R, Bzhilyanskaya V, Milzman D et al. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis. The American Journal of Emergency Medicine 2021; 43: 88-96. doi: 10.1016/j. ajem.2021.01.058
44. Wu C, Chen X, Cai Y, Zhou X, Xu S et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. The Journal of the American Medical Association Internal Medicine 2020; 180 (7): 934-943. doi: 10.1001/ jamainternmed.2020.0994
45. Grieco DL, Menga LS, Eleuteri D, Antonelli M. Patient selfinflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support. Minerva Anestesiologica 2019; 85 (9): 1014-1023. doi: 10.23736/S0375-9393.19.13418-9
46. Lee CP, Yip YY, Chan AK, Ko CP, Joynt GM. Early intubation versus late intubation for COVID-19 patients: An in situ simulation identifying factors affecting performance and infection control in airway management. Anaesthesia and Intensive Care 2021; 49 (4): 284-291. doi: 10.1177/0310057X211007862
47. Cabrini L, Ghislanzoni L, Severgnini P, Landoni G, Baiardo Redaelli M et al. Early versus late tracheal intubation in COVID-19 patients: a pro-con debate also considering heartlung interactions. Minerva Cardioangiologica 2020; Online ahead of print. doi: 10.23736/S0026-4725.20.05356-6
48. Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D et al. High-flow nasal cannula therapy in COVID-19: Using the ROX index to predict success. Respiratory Care 2021; 66 (6): 909-919. doi: 10.4187/respcare.08631
49. Roca O, Caralt B, Messika J, Samper M, Sztrymf B et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. American Journal of Respiratory and Critical Care Medicine 2019; 199 (11): 1368- 1376. doi: 10.1164/rccm.201803-0589OC
50. Scaravilli V, Grasselli G, Castagna L, Zanella A, Isgro S et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study. Journal of Critical Care 2015; 30 (6): 1390-1394. doi: 10.1016/j.jcrc.2015.07.008
51. Gu´erin C, Reignier J, Richard JC, Beuret P, Gacouin A et al. Prone positioning in severe acute respiratory distress syndrome. The New England Journal of Medicine 2013; 368 (23): 2159-2168. doi: 10.1056/NEJMoa1214103
52. Chua EX, Zahir SM, Ng KT, Teoh WY, Hasan MS et al. Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis. Journal of Clinical Anesthesia 2021; 74: 110406. doi: 10.1016/j. jclinane.2021.110406
53. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D et al. Effect of prone positioning on the survival of patients with acute respiratory failure. The New England Journal of Medicine 2001; 345 (8): 568-573. doi: 10.1056/NEJMoa010043
54. Pelosi P, Brazzi L, Gattinoni L. Prone position in acute respiratory distress syndrome. The European Respiratory Journal 2002; 20 (4): 1017-1028. doi: 10.1183/09031936.02.00401702
55. Nyr´en S, Radell P, Lindahl SG, Mure M, Petersson J et al. Lung ventilation and perfusion in prone and supine postures with reference to anesthetized and mechanically ventilated healthy volunteers. Anesthesiology 2010; 112 (3): 682-687. doi: 10.1097/ALN.0b013e3181cf40c8
56. Zarantonello F, Andreatta G, Sella G, Navalesi P. Prone position and lung ventilation and perfusion matching in acute respiratory failure due to COVID-19. American Journal of Respiratory and Critical Care Medicine 2020; 202 (2): 278-279. doi: 10.1164/rccm.202003-0775IM
57. Tobin MJ. Mechanical ventilation. The New England Journal of Medicine 1994; 330 (15): 1056-1061. doi: 10.1056/ NEJM199404143301507
58. Richter T, Bellani G, Scott Harris R, Melo MF, Winkler T et al. Effect of prone position on regional shunt, aeration, and perfusion in experimental acute lung injury. American Journal of Respiratory and Critical Care Medicine 2005; 172 (4): 480- 487. doi: 10.1164/rccm.200501-004OC
59. Pelosi P, Tubiolo D, Mascheroni D, Vicardi P, Crotti S et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. American Journal of Respiratory and Critical Care Medicine 1998; 157 (2): 387-393. doi: 10.1164/ajrccm.157.2.97-04023
60. Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Critical Care 2020; 24 (1):28. doi: 10.1186/s13054-020-2738-5
61. Fang XZ, Wang YX, Xu JQ, He YJ, Peng ZK et al. Immunothrombosis in acute respiratory dysfunction of COVID-19. Frontiers in Immunology 2021;12: 651545. doi: 10.3389/fimmu.2021.651545
62. Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS et al. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thrombosis Research 2020; 196: 67-74. doi: 10.1016/j.thromres.2020.08.020
63. Prakash A, Kaur S, Kaur C, Prabha PK, Bhatacharya A et al. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian Journal of Pharmacology 2021; 53 (3): 236-243. doi: 10.4103/ ijp.ijp_382_21
64. Halacli B, Kaya A, Topeli A. Critically-ill COVID-19 patient. Turkish Journal of Medical Sciences 2020; 50 (SI-1): 585-591. doi: 10.3906/sag-2004-122
65. Elavarasi A, Prasad M, Seth T, Sahoo RK, Madan K et al. Chloroquine and hydroxychloroquine for the treatment of COVID-19: A systematic review and meta-analysis. Journal of General Internal Medicine 2020; 35 (11): 3308-3314. doi: 10.1007/s11606-020-06146-w
66. Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N et al. Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and metaanalysis. Virology Journal 2020; 17 (1): 141. doi: 10.1186/ s12985-020-01412-z
67. Frediansyah A, Nainu F, Dhama K, Mudatsir M, Harapan H. Remdesivir and its antiviral activity against COVID-19: A systematic review. Clinical Epidemiology and Global Health 2021; 9: 123-127. doi: 10.1016/j.cegh.2020.07.011
68. Vargas M, Servillo G, Einav S. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review. European Review for Medical Pharmacological Sciences 2020; 24 (16): 8592-8605. doi: 10.26355/eurrev_202008_22659
69. Polak SB, Van Gool IC, Cohen D, von der Thüsen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Modern Pathology 2020; 33 (11): 2128-2138. doi: 10.1038/s41379-020-0603-3
70. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. The Journal of the American Medical Association 2020; 324 (13): 1330-1341. doi: 10.1001/jama.2020.17023
71. Kotak S, Khatri M, Malik M, Malik M, Hassan W et al. Use of Tocilizumab in COVID-19: A Systematic Review and MetaAnalysis of Current Evidence. Cureus 2020; 12 (10): e10869. doi:10.7759/cureus.10869
72. Somagutta MK, Pormento MK, Hamid P, Hamdan A, Khan MA et al. The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis. Infection & Chemotherapy 2021; 53 (2): 221-237. doi: 10.3947/ic.2021.0016
73. Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 2020; 40 (11): 1130-1151. doi: 10.1002/phar.2465